|
| |
Image Results
Loading...
Loading...
Chronogen Pages on BioPortfolio:
|
BioPortfolio - Chronogen, Inc. - Profile
View the current Chronogen, Inc. Page on BioPortfolio.com ... Initially, Chronogen has focused all activities on the identification and the
characterization ...
http://www.bioportfolio.com/biocorporate/20909-Chronogen,+In...
|
BioPortfolio - Biocorporate Search Quebec
Chronogen, Inc. With an aging population, the prevalence of age-related diseases is expected to mount rapidly ... www.chronogen-inc.com/ View full profile ...
http://www.bioportfolio.com/biocorporate/search/region/Quebe...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
... DYNAMAC | PPD Dabney Rd | t | Idexx Laboratories testing on animals | polybac | Chronogen Inc. | quark biotech | Mckesson Foundation | mehtapartners.
com ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...
|
BioPortfolio - Most Popular Pages on Biocorporate
Hindustan Lever Limited, 8405, 902. Argose Incorporated, 2959, 878. Ventana Clinical Research Corporation, 3455, 863. Chronogen, Inc. 2869, 843 ...
http://www.bioportfolio.com/biocorporate/mostlinkedout.php...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
... glaxosmithkline) AND (sales OR revenue OR profit) AND schein | Thuris | t | upstate | t | chronogen | merritt hawkins | t | Molecular Applications Group ...
http://www.bioportfolio.com/bookshop/ASIN/B000JJUEL2/...
| Results from other life science and pharmaceutical sites:
BioSpace - Chronogen Inc. News, Search Jobs, Events
26 Oct 2005 ... Chronogen Inc. Announces A Partnership With Sosei Co., Ltd. For The Screening Of The Sosei Drug Reprofiling Platform(R) Compound Library ...
http://www.biospace.com/company_profile.aspx?CompanyId=58612...
|
Evolutionary conservation of drug action on lipoprotein metabolism ...
Chronogen, Inc., Montréal, Québec, Canada. Genetic analysis has shown that the slower than normal rhythmic defecation behavior of the clk-1 mutants of ...
http://www.ncbi.nlm.nih.gov/pubmed/17901468...
|
Chronogen Inc. Receives Approval To Proceed With A Phase I/II ...
MONTREAL, April 26 /PRNewswire/ - Chronogen Inc. (Montreal, Canada), a drug discovery company developing novel therapeutics to treat oxidative stress ...
http://www.biospace.com/news_story.aspx?NewsEntityId=16441...
|
STATINS AND EZETIMIBE MODULATE PLASMA PROPROTEIN CONVERTASE ...
for Anthera, AstraZeneca, Bayer, BMS, Chronogen, Cortria, Fournier/Solvay, Genfit, Gen- zyme, LifeCycle Pharma, Merck, Merck Frosst/Schering, Oryx, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744528/pdf/tacc...
|
{1} Names Dr. Max Fehlmann, Ph.D. MB - News, Search Jobs, Events
4 Nov 2004 ... I feel that Chronogen has accomplished much in its last year of operation ... Chronogen is bound to make a number of strategic moves in the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1798792...
|
Company - Chlorion Pharma
Specifically, Dr. Kianicka has led or contributed to safety pharmacological and toxicological analyses at Vertex Pharmaceuticals, Chronogen, ...
http://www.chlorion.com/company.php...
|
BioSpace - Bionaut Pharmaceuticals, Inc. News, Search Jobs, Events
19 Oct 2005 ... Chronogen Inc. Names Mr. Kees Been, Chief Executive Officer Of Bionaut Pharmaceuticals, Inc. To Board Of Directors 10/19/2005 5:10:57 PM ...
http://www.biospace.com/company_profile.aspx?CompanyId=56042...
|
CGHS Notes Spring 05.indd
the Board of Directors of Chronogen, a drug discovery company developing therapeutics to treat age-dependent diseases, and on the Advisory Board of ...
http://www.utmem.edu/grad/Alumni/CGHS_Alum_Spring05.pdf...
|
Competing financial interests - Nature Genetics
Declaration: S.H. is the founder of, a shareholder of, and a consultant for Chronogen, a biotechnology company interested in aging research. ...
http://www.nature.com/ng/journal/v38/n9/box/ng1881_audecl.ht...
|
Statins and Ezetimibe Modulate Plasma Proprotein Convertase ...
Potential Conflicts of Interest: Dr. Davignon is or has been a consultant or scientific advisor for Anthera, AstraZeneca, Bayer, BMS, Chronogen, Cortria, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744528/...
|
|
